Dehydroepiandrosterone and sport

---

• 1.
• Williams JD. Textbook of endocrinology. Williams JD, Foster DW, editors. 8th ed. Philadelphia: WB Saunders, 1992; 579-581.
• 2.
• Greenspan FS. Basic and clinical endocrinology. 3rd ed. New Jersey: Prentice-Hall, 1991; 469-471.
• 3.
• Dehennin L, Ferry M, Lafarge P, et al. Oral administration of dehydroepiandrosterone to healthy men: alteration of the urinary androgen profile and consequences for the detection of abuse in sport by gas chromatography-mass spectrometry. Steroids 1998; 63: 80-87.
• 4.
• Bird CE, Masters V, Clark AF. Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin Invest Med 1984; 7: 119-122.
• 5.
• Haning RV Jr, Carlson IH, Flood CA, et al. Metabolism of dehydroepiandrosterone sulfate (DS) in normal women and women with high DS concentrations. J Clin Endocrinol Metab 1991; 73: 1210-1215.
• 6.
• Herbert J. The age of dehydroepiandrosterone [editorial]. Lancet 1995; 345: 1193-1194.
• 7.
• Labrie F, Belanger A, Simard J, et al. DHEA and peripheral androgen and estrogen formation: intracrinology. Ann N Y Acad Sci 1995; 774: 16-28.
• 8.
• Kent S. DHEA: "miracle" drug? Geriatrics 1982; 37: 157-161.
• 9.
• Skolnick AA. Scientific verdict still out on DHEA. JAMA 1996; 276: 1365-1367.
• 10.
• Kreeger KY. Researchers ponder the benefits of DHEA on many fronts. The Scientist 1997; 11(9): 11,14.
• 11.
• Dehydroepiandrosterone (DHEA). Med Lett Drugs Ther 1996; 38: 91-92.
• 12.
• Young J, Couzinet B, Nahoul K, et al. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab 1997; 82: 2578-2585.
• 13.
• Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol 1996; 150 Suppl: S125-S127.
• 14.
• Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994; 343: 1479-1481.
• 15.
• Liu CH, Laughlin G, Fischer U, et al. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990; 71: 900-906.
• 16.
• Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab 1996; 81: 3147-3151.
• 17.
• Nestler JE, Kahwash Z. Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans. J Clin Invest 1994; 94: 1484-1489.
• 18.
• Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988; 66: 57-61.
• 19.
• Regelson W, Loria R, Kalimi M. Dehydroepiandrosterone (DHEA) -- the "mother steroid". I. Immunologic action. Ann N Y Acad Sci 1994; 719: 553-563.
• 20.
• Arlt W, Justl H-G, Callies F, et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998; 83: 1928-1932.
• 21.
• Keizer H, Janssen GM, Menheere P, Kranenburg G. Changes in basal plasma testosterone, cortisol, and dehydroepiandrosterone sulfate in previously untrained males and females preparing for a marathon. Int J Sports Med 1989; 10 Suppl 3: S139-S145.
• 22.
• Velardo A, Pantaleoni M, Valerio L, et al. Influence of exercise on dehydroepiandrosterone sulphate and delta 4-androstenedione plasma levels in man. Exp Clin Endocrinol 1991; 97: 99-101.
• 23.
• Milani RV, Lavie CJ, Barbee RW, Littman AB. Lack of effect of exercise training on dehydroepiandrosterone-sulfate. Am J Med Sci 1995; 310: 242-246.
• 24.
• Johnson LG, Kraemer RR, Haltom R, et al. Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women. Fertil Steril 1997; 68: 836-843.
• 25.
• Barrett-Connor E, Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Ann N Y Acad Sci 1995; 774: 259-270.
• 26.
• Bulbrook RD, Hayward JL, Spicer CC, et al. Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet 1971; 2: 395-398.
• 27.
• Clore JN. Dehydroepiandrosterone and body fat. Obes Res 1995; 3 Suppl 4: 613S-616S.
• 28.
• Morales AJ, Nolan JJ, Nelson JC, et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-1367.
• 29.
• Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Ann N Y Acad Sci 1995; 774: 128-142.
• 30.
• Lifrak ET, Parker LN. Analysis of nonprescription capsules purported to contain an adrenal androgen. Am J Hosp Pharm 1985; 42: 587-589.
• 31.
• Sturmi JE, Diorio DJ. Anabolic agents. Clin Sports Med 1998; 17: 261-282.
• 32.
• Welle S, Jozefowicz R, Statt M. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab 1990; 71: 1259-1264.
• 33.
• Loria RM. Antiglucocorticoid function of androstenetriol. Psychoneuroendocrinology 1997; 22 Suppl 1: S103-S108.
• 34.
• Kalimi M, Shafagoj Y, Loria R, et al. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 1994; 131: 99-104.
• 35.
• Regelson W, Kalimi M. Dehydroepiandrosterone (DHEA) -- the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann N Y Acad Sci 1994; 719: 564-575.
• 36.
• Fleshner M, Pugh CR, Tremblay D, et al. DHEA-S selectively impairs contextual-fear conditioning: support for the antiglucocorticoid hypothesis. Behav Neurosci 1997; 111: 512-527.
• 37.
• Bosy TZ, Moore KA, Poklis A. The effect of oral dehydroepiandrosterone (DHEA) on the urine testosterone/epitestosterone (T/E) ratio in human male volunteers. J Anal Toxicol 1998; 22: 455-459.
• 38.
• Bowers LD. Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio. Clin Chem 1999; 45: 295-297.
• 39.
• Baulieu EE. Neurosteroids of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 1997; 52: 1-32.
• 40.
• Khorram O. DHEA: a hormone with multiple effects. Curr Opin Obstet Gynecol 1996; 8: 351-354.
• 41.
• Dubrovsky B. Natural steroids counteracting some actions of putative depressogenic steroids on the central nervous system: potential therapeutic benefits. Med Hypotheses 1997; 49: 51-55.
• 42.
• Corrigan AB. Anabolic steroids and the mind. Med J Aust 1996; 165: 222-226.
• 43.
• Miller RA. DHEA -- brass ring or red herring? [editorial]. J Am Ger Soc 1977; 45: 1402-1403.
• 44.
• Wang C, Alexander G, Berman N, et al. Testosterone replacement therapy improves mood in hypogonadal men -- a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3578-3583.
• 45.
• Imamura M, Prasad C. Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Biophys Res Commun 1998; 243: 771-775.
• 46.
• Magnay J. Days numbered for testosterone cheats. Sydney Morning Herald 1999; 16 July: 12.
• 47.
• Armsey TD, Green GA. Nutrition supplements: science vs hype. Phys Sportsmed 1997; 25: 77-92.
• 48.
• Dorgan JF, Stanczyk FZ, Longcope C, et al. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate and 5-androstene-3b,17b-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 1997; 6: 177-181.